ATE128188T1 - Menschliches gamma-interferon, verfahren zu seiner herstellung und seine verwendung. - Google Patents
Menschliches gamma-interferon, verfahren zu seiner herstellung und seine verwendung.Info
- Publication number
- ATE128188T1 ATE128188T1 AT89307374T AT89307374T ATE128188T1 AT E128188 T1 ATE128188 T1 AT E128188T1 AT 89307374 T AT89307374 T AT 89307374T AT 89307374 T AT89307374 T AT 89307374T AT E128188 T1 ATE128188 T1 AT E128188T1
- Authority
- AT
- Austria
- Prior art keywords
- huifn
- gamma
- production
- gamma interferon
- human gamma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63184069A JP2969461B2 (ja) | 1988-07-23 | 1988-07-23 | ヒトγ−インターフェロンとその製造方法並びに用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE128188T1 true ATE128188T1 (de) | 1995-10-15 |
Family
ID=16146838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89307374T ATE128188T1 (de) | 1988-07-23 | 1989-07-20 | Menschliches gamma-interferon, verfahren zu seiner herstellung und seine verwendung. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0353910B1 (de) |
JP (1) | JP2969461B2 (de) |
KR (1) | KR100190555B1 (de) |
AT (1) | ATE128188T1 (de) |
AU (1) | AU618382B2 (de) |
CA (1) | CA1340704C (de) |
DE (1) | DE68924316T2 (de) |
ES (1) | ES2096559T3 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05247078A (ja) * | 1992-03-03 | 1993-09-24 | Japan Tobacco Inc | 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体 |
EP0721780A3 (de) * | 1994-12-16 | 1997-12-17 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Mittel zur Förderung von Plättchen und/oder Leucozytenherstellung |
US6509313B1 (en) * | 1996-02-28 | 2003-01-21 | Cornell Research Foundation, Inc. | Stimulation of immune response with low doses of cytokines |
CA3108066A1 (en) * | 2018-07-30 | 2020-02-06 | The Board Of Trustees Of The Leland Stanford Junior University | Interferon-gamma biased agonists |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU184972B (en) * | 1981-12-01 | 1984-11-28 | Egyt Gyogyszervegyeszeti Gyar | Process for preparing human gamma interferone |
EP0107498B1 (de) * | 1982-10-25 | 1990-05-16 | Genentech, Inc. | Synergistische Humaninterferonaktivität |
IL71954A0 (en) * | 1983-06-01 | 1984-09-30 | Genentech Inc | Gamma interferon-lymphotoxin synergism |
DE3536939A1 (de) * | 1985-10-17 | 1987-04-23 | Hoechst Ag | Biologisch aktive derivate des human-(gamma)-interferons, ihre herstellung und arzneimittel, die solche derivate enthalten |
JP2632849B2 (ja) * | 1986-07-25 | 1997-07-23 | 株式会社 林原生物化学研究所 | γ―インターフェロンの製造方法 |
CA1340698C (en) * | 1986-07-25 | 1999-08-10 | Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo | Preparation and uses of interferon-gamma |
GB8619725D0 (en) * | 1986-08-13 | 1986-09-24 | Hoffmann La Roche | Homogenous interferon fragments |
-
1988
- 1988-07-23 JP JP63184069A patent/JP2969461B2/ja not_active Expired - Lifetime
-
1989
- 1989-07-06 CA CA000604905A patent/CA1340704C/en not_active Expired - Fee Related
- 1989-07-20 AT AT89307374T patent/ATE128188T1/de active
- 1989-07-20 ES ES89307374T patent/ES2096559T3/es not_active Expired - Lifetime
- 1989-07-20 EP EP89307374A patent/EP0353910B1/de not_active Expired - Lifetime
- 1989-07-20 DE DE68924316T patent/DE68924316T2/de not_active Expired - Fee Related
- 1989-07-21 AU AU38818/89A patent/AU618382B2/en not_active Ceased
- 1989-07-24 KR KR1019890010440A patent/KR100190555B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0353910A2 (de) | 1990-02-07 |
EP0353910B1 (de) | 1995-09-20 |
JP2969461B2 (ja) | 1999-11-02 |
CA1340704C (en) | 1999-08-10 |
AU3881889A (en) | 1990-01-25 |
KR100190555B1 (ko) | 1999-06-01 |
KR900003208A (ko) | 1990-03-26 |
AU618382B2 (en) | 1991-12-19 |
DE68924316D1 (de) | 1995-10-26 |
JPH02152998A (ja) | 1990-06-12 |
EP0353910A3 (en) | 1990-06-06 |
ES2096559T3 (es) | 1997-03-16 |
DE68924316T2 (de) | 1996-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE206757T1 (de) | Thrombin sowie verfahren zu seiner herstellung | |
ATE179330T1 (de) | Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute | |
ATE126433T1 (de) | Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen. | |
AT369385B (de) | Verfahren zur herstellung von 4'-epidaunorubicin und 3',4'-diepidaunorubicin | |
DE68927949D1 (de) | 3,9-Diphosphaspiroundecane und Verfahren zur Herstellung von 3,9-Diphosphaspiroundecanen | |
DE69427955D1 (de) | Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern | |
ATE128188T1 (de) | Menschliches gamma-interferon, verfahren zu seiner herstellung und seine verwendung. | |
DE69217192D1 (de) | Verfahren zur Herstellung von 2-Alkoxymethylakrolein und seine Verwendung zur Herstellung von 3-Alkoxymethylchinolinen | |
ATE164882T1 (de) | Verfahren zur herstellung von aktivierten killer- monozyten und verfahren zur überprüfung ihrer tumoriziden aktivität | |
FI901371A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi | |
DE3865484D1 (de) | Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid. | |
DE59304804D1 (de) | Verfahren zur Herstellung von 3-(2'-Oxyethyl)-dihydro-2-(3H)furanonen | |
ATE11911T1 (de) | N-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4amino-5-methylsulfamoyl-benzamide, verfahren zur herstellung und verwendung als heilmittel. | |
DE69025689D1 (de) | Verfahren zur Herstellung von menschlicher Thiroid-Peroxydase | |
DE3152571A1 (de) | Verfahren zur herstellung und verwendung von intravenoesen naehrstoffzusammensetzungen | |
DE3777709D1 (de) | Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis. | |
DE68926222D1 (de) | Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen | |
DE59504374D1 (de) | Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen | |
DE69326822D1 (de) | Katalysator und Verfahren zur Herstellung von Kohlensäurediestern | |
ATE40648T1 (de) | Behandlung von gegen interferon empfindliche krankheiten, verfahren und vorrichtung zur herstellung von -g(g)-interferon. | |
DE69103294D1 (de) | Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten. | |
PT80121A (de) | Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens | |
SE9003140D0 (sv) | Method and composition for treatment of heart diseases | |
DE3880072D1 (de) | N-phenyl-2,2,6,6-tetrahalogencyclohexanimin und verfahren zur herstellung von derivaten des 2,2,6,6-tetrahalogencyclohexanimins und von derivaten des 2,6-dihalogenanilins. | |
ATE96029T1 (de) | Zusammensetzung und verfahren zur behandlung von hepatitisvirusinfektionen unter verwendung von 1(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5- ethyluracil. |